ARCA Biopharma Inc (NASDAQ:ABIO)
| 1.87 Data as of Mar 07 |  -0.025 / -1.32%Today’s Change | 1.13 Today|||52-Week Range 3.93 | +11.31% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 1.90 |
| Today’s open | 1.90 |
| Day’s range | 1.86 - 1.90 |
| Volume | 216,405 |
| Average volume (3 months) | 1,075,343 |
| Market cap | $29.6M |
| Dividend yield | -- |
Data as of 3:59pm ET, 03/07/2014
Growth & Valuation
| Earnings growth (last year) | +38.99% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VTUSVentrus Biosciences ... | +0.02 | +1.43% |
| PRPHProPhase Labs Inc | -0.08 | -4.21% |
| ---- | ||
| CBLICleveland Biolabs In... | -0.02 | -3.25% |
Data as of 4:00pm ET, 03/07/2014
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Michael R. Bristow |
Chief Financial & Accounting Officer Patrick M. Wheeler |
Corporate headquarters Broomfield, Colorado |
Forecasts
